BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36248979)

  • 21. Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach.
    Fh T; Cyw C; Eyw C
    BJR Open; 2021; 3(1):20200073. PubMed ID: 34381946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades.
    Wu W; Ye J; Wang Q; Luo J; Xu S
    Front Oncol; 2019; 9():821. PubMed ID: 31544063
    [No Abstract]   [Full Text] [Related]  

  • 24. Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma.
    Amini M; Nazari M; Shiri I; Hajianfar G; Deevband MR; Abdollahi H; Arabi H; Rahmim A; Zaidi H
    Phys Med Biol; 2021 Oct; 66(20):. PubMed ID: 34544053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics outperforms clinical factors in characterizing human papilloma virus (HPV) for patients with oropharyngeal squamous cell carcinomas.
    Bagher-Ebadian H; Siddiqui F; Ghanem AI; Zhu S; Lu M; Movsas B; Chetty IJ
    Biomed Phys Eng Express; 2022 Jun; 8(4):. PubMed ID: 34781281
    [No Abstract]   [Full Text] [Related]  

  • 26.
    Carles M; Fechter T; Grosu AL; Sörensen A; Thomann B; Stoian RG; Wiedenmann N; Rühle A; Zamboglou C; Ruf J; Martí-Bonmatí L; Baltas D; Mix M; Nicolay NH
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma.
    Haider SP; Mahajan A; Zeevi T; Baumeister P; Reichel C; Sharaf K; Forghani R; Kucukkaya AS; Kann BH; Judson BL; Prasad ML; Burtness B; Payabvash S
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):2978-2991. PubMed ID: 32399621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
    Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
    Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiblock Discriminant Analysis of Integrative
    Lee SH; Kao GD; Feigenberg SJ; Dorsey JF; Frick MA; Jean-Baptiste S; Uche CZ; Cengel KA; Levin WP; Berman AT; Aggarwal C; Fan Y; Xiao Y
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1451-1465. PubMed ID: 33662459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images.
    Sellami S; Bourbonne V; Hatt M; Tixier F; Bouzid D; Lucia F; Pradier O; Goasduff G; Visvikis D; Schick U
    Acta Oncol; 2022 Jan; 61(1):73-80. PubMed ID: 34632924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of quantitative
    Martens RM; Koopman T; Noij DP; Pfaehler E; Übelhör C; Sharma S; Vergeer MR; Leemans CR; Hoekstra OS; Yaqub M; Zwezerijnen GJ; Heymans MW; Peeters CFW; de Bree R; de Graaf P; Castelijns JA; Boellaard R
    EJNMMI Res; 2020 Sep; 10(1):102. PubMed ID: 32894373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction.
    Starke S; Zwanenburg A; Leger K; Zöphel K; Kotzerke J; Krause M; Baumann M; Troost EGC; Löck S
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
    Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
    Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
    Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
    Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients.
    Ger RB; Zhou S; Elgohari B; Elhalawani H; Mackin DM; Meier JG; Nguyen CM; Anderson BM; Gay C; Ning J; Fuller CD; Li H; Howell RM; Layman RR; Mawlawi O; Stafford RJ; Aerts H; Court LE
    PLoS One; 2019; 14(9):e0222509. PubMed ID: 31536526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
    Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
    Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
    Dasgupta A; Fatima K; DiCenzo D; Bhardwaj D; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
    Cancer Med; 2021 Apr; 10(8):2579-2589. PubMed ID: 33314716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.